Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Polsky

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Journal of Medical Genetics|January 22, 2015
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanomaJustin Rendleman, Matjaz Vogelsang, Anuj Bapodra, et al.
Nature|December 24, 2010
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8Avnish Kapoor, Matthew S Goldberg, Lara K Cumberland, et al.
Journal of the National Cancer Institute|May 29, 2008
Frequent p16-independent inactivation of p14ARF in human melanomaDaniel E Freedberg, Sushila H Rigas, Julie Russak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorMiguel F Segura, Douglas Hanniford, Silvia Menendez, et al.
Journal of Translational Medicine|November 26, 2008
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patientsJessie Z Yu, Melanie A Warycha, Paul J Christos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanomaElnaz F Firoz, Melanie Warycha, Jan Zakrzewski, et al.
Cancer Immunity|July 13, 2007
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factorsElsa F Velazquez, Achim A Jungbluth, Molly Yancovitz, et al.
The Journal of Investigative Dermatology|February 23, 2020
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma TumorsGregory A Chang, Jennifer M Wiggins, Broderick C Corless, et al.
Journal of the National Cancer Institute|June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to TherapyMichael Lattanzi, Yesung Lee, Danny Simpson, et al.
Journal of Translational Medicine|January 9, 2007
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanomaElsa F Velazquez, Molly Yancovitz, Anna Pavlick, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Journal of Medical Genetics|January 22, 2015
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanomaJustin Rendleman, Matjaz Vogelsang, Anuj Bapodra, et al.
Nature|December 24, 2010
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8Avnish Kapoor, Matthew S Goldberg, Lara K Cumberland, et al.
Journal of the National Cancer Institute|May 29, 2008
Frequent p16-independent inactivation of p14ARF in human melanomaDaniel E Freedberg, Sushila H Rigas, Julie Russak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorMiguel F Segura, Douglas Hanniford, Silvia Menendez, et al.
Journal of Translational Medicine|November 26, 2008
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patientsJessie Z Yu, Melanie A Warycha, Paul J Christos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanomaElnaz F Firoz, Melanie Warycha, Jan Zakrzewski, et al.
Cancer Immunity|July 13, 2007
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factorsElsa F Velazquez, Achim A Jungbluth, Molly Yancovitz, et al.
The Journal of Investigative Dermatology|February 23, 2020
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma TumorsGregory A Chang, Jennifer M Wiggins, Broderick C Corless, et al.
Journal of the National Cancer Institute|June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to TherapyMichael Lattanzi, Yesung Lee, Danny Simpson, et al.
Journal of Translational Medicine|January 9, 2007
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanomaElsa F Velazquez, Molly Yancovitz, Anna Pavlick, et al.
Pageof 12